087010.KQ Peptron, Inc.
KOEHealthcareAs of 2026-08-09 03:15
Why 087010.KQ matters now
Peptron, Inc. (087010.KQ) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩181,800.00 with +2.13% on the session and ₩4.24T in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E -254.50, gross margin 11.7%, and operating margin -379.2%.
Valuation
P/E (TTM)
-254.50
PEG
—
P/B
31.08
P/S
706.49
EV/EBITDA
-202.69
DCF Value
—
FCF Yield
-0.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
11.7%
Operating Margin
-379.2%
Net Margin
-277.8%
ROE
-11.7%
ROA
-9.5%
ROIC
-12.9%
Listing Info
Market
Korea
Exchange
KOE
Currency
KRW
Sector
Healthcare
Industry
Biotechnology
Country
KR
Peptron, Inc. specializes in the creation of peptide-based pharmaceuticals designed to manage chronic health conditions. The company's technological expertise encompasses advanced long-acting drug delivery systems and SmartDepot, an ultrasonic spray-drying technique utilized for developing sustained-release injectable microsphere drug formulations. Their research and development pipeline features several key products: Luphere Depot, which addresses prostate cancer, endometriosis, uterine fibroids, and puberty-related issues; SR-Octreotide (PT201) for treating acromegaly; SR-Exenatide (PT302) for type 2 diabetes; and SR-Exenatide (PT320), which is aimed at Parkinson's and Alzheimer's diseases. Founded in 1997, Peptron, Inc. is headquartered in Daejeon, South Korea.